Literature DB >> 31932853

Cerebrofacial venous metameric syndrome-spectrum of imaging findings.

Waleed Brinjikji1,2, Patrick Nicholson3, Christopher A Hilditch3, Timo Krings3, Vitor Pereira3, Ronit Agid3.   

Abstract

Cerebrofacial venous metameric syndrome (CVMS) is a complex craniofacial vascular malformation disorder in which patients have a constellation of venous vascular malformations affecting soft tissues, bone, dura, and neural structures including the eye and brain. It is hypothesized that a somatic mutation responsible for the venous abnormalities occurred prior to migration of the neural crest cells, and because of this, facial, osseous, and cerebral involvement typically follows a segmental or "metameric" distribution. The most commonly recognized form of CVMS is Sturge-Weber syndrome. However, a wide spectrum of CVMS phenotypical presentations exist with various metameric distributions of slow-flow vascular lesions including facial venous vascular malformations, developmental venous anomalies, venous angiomas, cavernous malformations (cavernomas), dural sinus malformations, and maybe even vascular tumors such as cavernous hemangiomas. Awareness of the various manifestations as described herewith is important for treatment and screening purposes.

Entities:  

Keywords:  Cavernous malformations; Congenital; Developmental venous anomaly; Hemangioma; Sturge-Weber; Venous vascular malformations

Year:  2020        PMID: 31932853     DOI: 10.1007/s00234-020-02362-7

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  21 in total

Review 1.  Sturge-Weber syndrome.

Authors:  Anne M Comi
Journal:  Handb Clin Neurol       Date:  2015

Review 2.  Segmental neurovascular syndromes in children.

Authors:  T Krings; S Geibprasert; C B Luo; J J Bhattacharya; H Alvarez; Pierre Lasjaunias
Journal:  Neuroimaging Clin N Am       Date:  2007-05       Impact factor: 2.264

3.  GNA14 Somatic Mutation Causes Congenital and Sporadic Vascular Tumors by MAPK Activation.

Authors:  Young H Lim; Antonella Bacchiocchi; Jingyao Qiu; Robert Straub; Anna Bruckner; Lionel Bercovitch; Deepak Narayan; Jennifer McNiff; Christine Ko; Leslie Robinson-Bostom; Richard Antaya; Ruth Halaban; Keith A Choate
Journal:  Am J Hum Genet       Date:  2016-07-28       Impact factor: 11.025

4.  Cerebrofacial Venous Metameric Syndrome 2 plus 3: Facial and Cerebral Manifestations.

Authors:  R Agid; K G Terbrugge
Journal:  Interv Neuroradiol       Date:  2007-06-27       Impact factor: 1.610

5.  Sturge-Weber disease with repercussion on the prenatal development of the cerebral hemisphere.

Authors:  Pilar Portilla; Beatrice Husson; Pierre Lasjaunias; Pierre Landrieu
Journal:  AJNR Am J Neuroradiol       Date:  2002-03       Impact factor: 3.825

6.  Venous anomalies and abnormalities of the posterior fossa.

Authors:  A Goulao; H Alvarez; R Garcia Monaco; P Pruvost; P Lasjaunias
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

7.  Cerebrofacial venous metameric syndrome (CVMS) 3: Sturge-Weber syndrome with bilateral lymphatic/venous malformations of the mandible.

Authors:  N Ramli; M Sachet; C Bao; P Lasjaunias
Journal:  Neuroradiology       Date:  2003-09-13       Impact factor: 2.804

8.  Somatic Activating PIK3CA Mutations Cause Venous Malformation.

Authors:  Nisha Limaye; Jaakko Kangas; Antonella Mendola; Catherine Godfraind; Matthieu J Schlögel; Raphael Helaers; Lauri Eklund; Laurence M Boon; Miikka Vikkula
Journal:  Am J Hum Genet       Date:  2015-12-03       Impact factor: 11.025

9.  Cerebral developmental venous anomalies associated with head and neck venous malformations.

Authors:  M Boukobza; O Enjolras; J P Guichard; F Gelbert; D Herbreteau; D Reizine; J J Merland
Journal:  AJNR Am J Neuroradiol       Date:  1996-05       Impact factor: 3.825

10.  Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapy.

Authors:  Lara Al-Olabi; Satyamaanasa Polubothu; Katherine Dowsett; Katrina A Andrews; Paulina Stadnik; Agnel P Joseph; Rachel Knox; Alan Pittman; Graeme Clark; William Baird; Neil Bulstrode; Mary Glover; Kristiana Gordon; Darren Hargrave; Susan M Huson; Thomas S Jacques; Gregory James; Hannah Kondolf; Loshan Kangesu; Kim M Keppler-Noreuil; Amjad Khan; Marjorie J Lindhurst; Mark Lipson; Sahar Mansour; Justine O'Hara; Caroline Mahon; Anda Mosica; Celia Moss; Aditi Murthy; Juling Ong; Victoria E Parker; Jean-Baptiste Rivière; Julie C Sapp; Neil J Sebire; Rahul Shah; Branavan Sivakumar; Anna Thomas; Alex Virasami; Regula Waelchli; Zhiqiang Zeng; Leslie G Biesecker; Alex Barnacle; Maya Topf; Robert K Semple; E Elizabeth Patton; Veronica A Kinsler
Journal:  J Clin Invest       Date:  2018-03-12       Impact factor: 14.808

View more
  5 in total

1.  Intracranial and extracranial vascular manifestations of patients with a clinical diagnosis of Klippel-Trenaunay syndrome.

Authors:  Tristan N Covington; Katelyn R Anderson; Megha M Tollefson; Julie B Guerin; Waleed Brinjikji
Journal:  Neuroradiology       Date:  2020-10-16       Impact factor: 2.804

Review 2.  Imaging of benign cervicofacial vascular anomalies and associated syndromes.

Authors:  Anthony S Larson; Waleed Brinjikji; Katelyn R Anderson; Megha Tollefson; V Michelle Silvera; Julie B Guerin
Journal:  Interv Neuroradiol       Date:  2021-08-16       Impact factor: 1.764

Review 3.  The cerebrofacial metameric syndromes: An embryological review and proposal of a novel classification scheme.

Authors:  Anthony S Larson; Waleed Brinjikji; Timo Krings; Julie B Guerin
Journal:  Interv Neuroradiol       Date:  2021-10-19       Impact factor: 1.764

4.  Paediatric intracranial dural arteriovenous shunts: types, clinical presentation and therapeutic management.

Authors:  Stanislas J Smajda; Michael Söderman; Georg Dorfmüller; Nathalie Dorison; Marie-Claire Nghe; Georges L Rodesch
Journal:  Brain Commun       Date:  2022-02-23

5.  Cerebrofacial vascular metameric syndrome associated with Moyamoya syndrome: a rare case report.

Authors:  Aldo José F da Silva; Ana Carolina de Carvalho Ruela Pires; Lara Cansanção Lopes de Farias; Carla Roberta Vieira da Silva
Journal:  Childs Nerv Syst       Date:  2021-06-18       Impact factor: 1.475

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.